Your browser doesn't support javascript.
loading
Immune checkpoint inhibition in muscle-invasive and locally advanced bladder cancer.
Gust, Kilian M; Rebhan, Katharina; Resch, Irene; Shariat, Shahrokh F; Necchi, Andrea.
Affiliation
  • Gust KM; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna.
  • Rebhan K; Karl Landsteiner Institute, Vienna, Austria.
  • Resch I; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna.
  • Necchi A; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna.
Curr Opin Urol ; 30(4): 547-556, 2020 07.
Article in En | MEDLINE | ID: mdl-32453001
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Clinical Trials, Phase II as Topic / Neoadjuvant Therapy / Immune Checkpoint Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Opin Urol Journal subject: UROLOGIA Year: 2020 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell / Clinical Trials, Phase II as Topic / Neoadjuvant Therapy / Immune Checkpoint Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Opin Urol Journal subject: UROLOGIA Year: 2020 Document type: Article Country of publication: United States